Alfred Sandrock's Net Worth
$29.4 Million
Who is Alfred Sandrock?
Alfred Sandrock has an estimated net worth of $29.4 Million. This is based on reported shares across multiple companies, which include BIOGEN INC., NEUROCRINE BIOSCIENCES INC, and Voyager Therapeutics, Inc..
SEC CIK
Alfred Sandrock's CIK is 0001577061
Past Insider Trading and Trends
2014 was Alfred Sandrock's most active year for acquiring shares with 7 total transactions. Alfred Sandrock's most active month to acquire stocks was the month of January. 2015 was Alfred Sandrock's most active year for disposing of shares, totalling 24 transactions. Alfred Sandrock's most active month to dispose stocks was the month of January. 2013 saw Alfred Sandrock paying a total of $1,397,779.80 for 24,850 shares, this is the most they've acquired in one year. In 2013 Alfred Sandrock cashed out on 50,533 shares for a total of $6,355,832.06, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOGEN INC. (BIIB) Snapshot price: $245.55
Head Research & Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -43.00% | -7.67K |
$440.00 | -$3,375,680.00 | 10.17K |
Scheduled
|
Jun 7
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
| +5.62% | 944 |
$278.03 | -$975,885.30 | 17.74K |
Feb 12
| |||
Form 4
| +28.53% | 3.73K |
—
|
—
| 16.79K |
Jan 27
| |||
Form 4
| -10.30% | -1.50K |
$350.00 | -$525,000.00 | 13.07K |
Scheduled
|
Nov 4
| ||
Form 4
| +4.89% | 675 |
$333.00 | -$179,154.00 | 14.48K |
Feb 15
| |||
Form 4
| +31.60% | 3.31K |
$331.76 | -$630,675.76 | 13.81K |
Feb 12
| |||
Form 4
| +9.74% | 924 |
$325.33 | -$240,418.87 | 10.41K |
Feb 22
| |||
Form 4
| +8.36% | 732 |
$332.87 | -$195,061.82 | 9.49K |
Feb 15
| |||
Form 4
| +32.06% | 2.13K |
$319.43 | -$804,324.74 | 8.75K |
Feb 12
| |||
Form 4
| -3.80% | -259.00 |
$290.83 | -$75,324.97 | 6.55K |
Scheduled
|
Feb 27
| ||
Form 4
| -8.70% | -649.00 |
$293.32 | -$327,341.76 | 6.81K |
Scheduled
|
Feb 23
| ||
Form 4
| +13.86% | 908 |
$284.81 | -$207,056.87 | 7.46K |
Feb 22
| |||
Form 4
| -10.18% | -743.00 |
$292.00 | -$216,956.00 | 6.55K |
Scheduled
|
Feb 20
| ||
Form 4
| -15.06% | -1.29K |
$298.85 | -$386,711.90 | 7.3K |
Scheduled
|
Feb 15
| ||
Form 4
| +9.47% | 743 |
$299.38 | -$178,430.48 | 8.59K |
Feb 15
| |||
Form 4
| +9.73% | 696 |
$316.63 | -$416,685.08 | 7.85K |
Feb 12
| |||
Form 4
| -21.91% | -1.98K |
$274.08 | -$542,952.48 | 7.06K |
Scheduled
|
Apr 3
| ||
Form 4
| -9.72% | -973.00 |
$290.07 | -$282,238.11 | 9.04K |
Scheduled
|
Mar 1
| ||
Form 4
| +21.97% | 1.8K |
$278.17 | -$829,217.21 | 10.01K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
| -2.24% | -183.00 |
$261.90 | -$47,927.70 | 7.99K |
Scheduled
|
Feb 25
| ||
Form 4
| +2.29% | 183 |
$258.99 | -$42,474.36 | 8.17K |
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| -8.29% | -722.00 |
$256.16 | -$184,947.52 | 7.99K |
Scheduled
|
Feb 17
| ||
Form 4
| +12.56% | 972 |
$247.22 | -$451,670.94 | 8.71K |
Feb 12
| |||
Form 4
|
—
|
0
|
$247.95 | -$316,880.10 | 7.74K |
Scheduled
|
Feb 8 - Feb 9
| ||
Form 4
| -9.73% | -834.00 |
$276.26 | -$230,404.92 | 7.74K |
Scheduled
|
Dec 3 - Dec 4
| ||
Form 4
| -4.78% | -430.00 |
$430.12 | -$184,951.60 | 8.57K |
Scheduled
|
Mar 27
| ||
Form 4
| -39.99% | -6.00K |
$409.54 | -$2,457,216.07 | 9K |
Scheduled
|
Mar 1 - Mar 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| -2.71% | -418.00 |
$389.11 | -$162,647.98 | 15K |
Scheduled
|
Feb 17
| ||
Form 4
| +5.82% | 848 |
$392.11 | -$296,827.27 | 15.42K |
Feb 12
| |||
Form 4
| -7.27% | -1.14K |
$398.11 | -$455,038.98 | 14.57K |
Scheduled
|
Feb 10
| ||
Form 4
| +7.84% | 1.14K |
$398.49 | -$780,248.08 | 15.72K |
Scheduled
|
Feb 8 - Feb 9
| ||
Form 4
| -5.41% | -833.00 |
$346.57 | -$288,691.82 | 14.57K |
Scheduled
|
Dec 3 - Dec 4
| ||
Form 4
| -17.07% | -3.17K |
$342.58 | -$1,086,321.18 | 15.41K |
Scheduled
|
Mar 4
| ||
Form 4
| -13.22% | -2.83K |
$340.68 | -$963,783.72 | 18.58K |
Mar 3
| |||
Form 4
| -4.67% | -1.05K |
$342.17 | -$358,594.16 | 21.41K |
Scheduled
|
Feb 26
| ||
Form 4
| +4.90% | 1.05K |
$347.11 | -$326,283.40 | 22.45K |
Feb 23
| |||
Form 4
| +56.63% | 7.74K |
$319.49 | -$253,033.33 | 21.41K |
Scheduled
|
Feb 12 - Feb 13
| ||
Form 4
| -13.24% | -2.08K |
$314.31 | -$655,336.35 | 13.67K |
Scheduled
|
Feb 11
| ||
Form 4
| +15.26% | 2.08K |
$315.54 | -$320,588.64 | 15.75K |
Feb 8 - Feb 9
| |||
Form 4
| -5.74% | -833.00 |
$286.78 | -$238,887.54 | 13.67K |
Scheduled
|
Dec 3 - Dec 4
| ||
Form 4
|
—
|
0
|
$155.34 | -$2,848,906.44 | 14.5K |
Scheduled
|
Oct 22
| ||
Form 4
|
—
|
0
|
$144.88 | -$1,870,258.28 | 14.5K |
Scheduled
|
Sep 16
| ||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEUROCRINE BIOSCIENCES INC (NBIX) Snapshot price: $135
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Voyager Therapeutics, Inc. (VYGR) Snapshot price: $7.465
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.62% | -12.12K |
$9.86 | -$119,453.90 | 322.84K |
Apr 2
| |||
Form 4
| -3.75% | -13.03K |
$7.46 | -$97,226.18 | 334.95K |
Feb 21
| |||
Form 4
| +59.64% | 130K |
—
|
—
| 347.99K |
Feb 9
| |||
Form 4
| -3.35% | -7.44K |
$7.83 | -$58,231.71 | 214.62K |
Apr 3
| |||
Form 4
| +117.58% | 120K |
—
|
—
| 222.06K |
Feb 17
| |||
Form 4
|
∞
| 100K |
—
|
—
| 100K |
Mar 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||